☰

Kaijie He, Ph.D. - Publications

Affiliations: 
2012 Molecular Biology University of Southern California, Los Angeles, CA, United States 
Area:
Molecular Biology, Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 He K, You H, Li Y, Cui L, Zhang J, He W. TCRγ4δ1-engineered αβT cells exhibit effective antitumor activity. Molecular Medicine (Cambridge, Mass.). 22. PMID 27463149 DOI: 10.2119/Molmed.2016.00023  0.304
2016 He K, Qu H, Xu LN, Gao J, Cheng FY, Xiang P, Zhou CQ. Epigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells. Bioscience Reports. PMID 27377320 DOI: 10.1042/BSR20160104  0.382
2016 He K, Chen D, Ruan H, Li X, Tong J, Xu X, Zhang L, Yu J. BRAFV600E-dependent Mcl-1 stabilization leads to everolimus resistance in colon cancer cells. Oncotarget. PMID 27351224 DOI: 10.18632/Oncotarget.10277  0.348
2016 Chen Y, Jiang T, Shi L, He K. hcrcn81 promotes cell proliferation through Wnt signaling pathway in colorectal cancer. Medical Oncology (Northwood, London, England). 33: 3. PMID 26607374 DOI: 10.1007/s12032-015-0713-9  0.312
2014 He K, Xu T, Xu Y, Ring A, Kahn M, Goldkorn A. Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway. International Journal of Cancer. Journal International Du Cancer. 134: 43-54. PMID 23784558 DOI: 10.1002/Ijc.28341  0.646
2012 He K, Xu T, Xu Y, Kahn M, Goldkorn A. Abstract 3320: Plasticity between the cancer stem-like and non cancer stem-like states is regulated by the PI3K/Akt/β-catenin/CBP pathway Cancer Research. 72: 3320-3320. DOI: 10.1158/1538-7445.Am2012-3320  0.599
2011 Xu Y, He K, Goldkorn A. Telomerase targeted therapy in cancer and cancer stem cells. Clinical Advances in Hematology & Oncology : H&O. 9: 442-55. PMID 21841744  0.605
2011 He K, Xu T, Goldkorn A. Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotype. Molecular Cancer Therapeutics. 10: 938-48. PMID 21518726 DOI: 10.1158/1535-7163.Mct-10-1120  0.633
2011 Xu T, He K, Wang L, Goldkorn A. Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference. The Prostate. 71: 1390-400. PMID 21321978 DOI: 10.1002/Pros.21355  0.592
2010 He K, Xu T, Goldkorn A. Abstract 5152: Cancer stem cells arise directly from differentiated cancer cells: A new model of dynamic equilibrium modulated by the Akt pathway Cancer Research. 70: 5152-5152. DOI: 10.1158/1538-7445.Am10-5152  0.638
Show low-probability matches.